An update on prodrugs from natural products

Asian Pacific Journal of Tropical Medicine

Volumn 7, Issue S1, 2014, Pages S54-S59

  Kumar, Sekar Vinoth ^b   Saravanan, Devarajan ^a   Kumar, Balasubramanian ^a   Jayakumar, Annamalai ^a  

^a Ratnam Institute of Pharmacy   (India)

^b Gokula Krishna College of Pharmacy   (India)

Author keywords

Natural products; Pharmacology; Prodrugs

Indexed keywords

EID: 84908164453     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(14)60203-0     Document Type: Article

References (29)

1. Beghyn T, Deprez-Poulain R, Willand N, Folleas B, Deprez B Natural compounds: leads or ideas? Bioinspired molecules for drug discovery. Chem Biol Drug Des 2008, 72(1):3-15.
2. Newman DJ, Cragg GM Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007, 70(3):461-477.
3. Dossey AT Insects and their chemical weaponry: new potential for drug discovery. Nat Prod Rep 2010, 27(12):1737-1757.
4. Paterson I, Anderson EA Chemistry. The renaissance of natural products as drug candidates. Science 2005, 310:451-453.
5. Balunas MJ, Kinghorn AD Drug discovery from medicinal plants. Life Sci 2005, 78(5):431-441.
6. Bucar F, Wube A, Schmid M Natural product isolation-how to get from biological material to pure compounds. Nat Prod Rep 2013, 30(4):525-545.
7. Butler MS Natural products to drugs: natural products derived compounds in clinical trials. Nat Prod Rep 2008, 25(3):475-516.
8. Karen MV, William M, Cedric JP, Nicholas HO Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma. J Antibiot (Tokyo) 2011, 64(8):525-531.
9. Greshock TJ, Johns DM, Noguchi Y, Williams RM Improved total synthesis of the potent HDAC inhibitor FK228 (FR-901228). Org Lett 2008, 10(4):613-616.
10. Heidor R, Ortega JF, de Conti A, Ong TP, Mnreno FS Anticarcinogenic actions of tributyrin, a butyric acid prodrug. Curr Drug Targets 2012, 13(14):1720-1729.
11. John WA Teonanacatl: ancient and contemporary shamanic mushroom names of Mesoamerica and other regions of the world 2007, John W Allen Psilly Publications and Raver Books, Washington.
12. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 2010, 285(11):8340-8351.
13. Salvador LA, Luesch H Discovery and mechanism of natural products as modulators of histone acetylation. Curr Drug Targets 2012, 13(8):1029-1047.
14. Lesch JE The first miracle drugs: how the sulfa drugs transformed medicine 2007, Oxford University Press, New York.
15. Schep LJ, Knudsen K, Slaughter RJ, Vale JA, Mégarbane B The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol. Clin Toxicol (Phila) 2012, 50(6):458-470.
16. Tordjman S, Najjar I, Bellissant E, Anderson GM, Barburoth M, Cohen D, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci 2013, 14(10):20508-20542.
17. Giwercman A Estrogen and phytoestrogen in male infertility. Curr Opin Urol 2011, 21(6):519-526.
18. Tarragó T, Kichik N, Claasen B, Prades R, Teixidó M, Giralt E Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor. Bioorg Med Chem 2008, 16(15):7516-7524.
19. Ramadan M, Goeters S, Watzer B, Krause E, Lohmann K, Bauer R, et al. Chamazulene carboxylic acid and matricin: a natural profen and its natural prodrug, identified through similarity to synthetic drug substances. J Nat Prod 2006, 69(7):1041-1045.
20. Ji HF, Li XJ, Zhang HY Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?. EMBO Rep 2009, 10(3):194-200.
21. Ashfaq UA, Masoud MS, Nawaz Z, Riazuddin S Glycyrrhizin as antiviral agent against hepatitis C virus. J Transl Med 2011, 9:112.
22. Patel D, Patel K, Tahilyani V Barbaloin: a concise report of its pharmacological and analytical aspects. Asian Pac J Trop Biomed 2012, 2(10):835-838.
23. Yang YS, Zhang T, Yu SC, Ding Y, Zhang LY, Qiu C, et al. Transformation of geniposide into genipin by immobilized β-glucosidase in a two-phase aqueous-organic system. Molecules 2011, 16(5):4295-4304.
24. Hung JY, Yang CJ, Tsai YM, Huang HW, Huang MS Antiproliferative activity of paeonif0lorin is through cell cycle arrest and the fas/fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol 2008, 35(2):141-147.
25. Peterson J, Dwyer J, Adlercreutz H, Scalbert A, Jacques P, McCullough ML Dietary lignans: physiology and potential for cardiovascular disease risk reduction. Nutr Rev 2010, 68(10):571-603.
26. Seenivasan A, Subhagar S, Aravindan R, Viruthagiri T Microbial production and biomedical applications of lovastatin. Indian J Pharm Sci 2008, 70(6):701-709.
27. Kai G, Sharma D, Vaishnav Y, Deshmukh VS A review on drug designing, methods, its applications and prospects. Int J Pharm Res Dev 2013, 5(5):15-30.
28. Vlachojannis J, Magora F, Chrubasik S Willow species and aspirin: different mechanism of actions. Phytother Res 2011, 25(7):1102-1104.
29. Kim DH, Shin J, Kwon HJ Psammaplin A is a natural prodrug that inhibits class I histone deacetylase. Exp Mol Med 2007, 39(1):47-55.